|
Meropenem is an ultra-broad spectrum injectable antibiotic for a wide kind of good contagions, including meningitis and pneumonia.
Meropenem was developed by Sumitomo Pharmaceuticals. These are marketed outside Japan by AstraZeneca with the brand Merrem & Meronem.
Unlike imipenem, it is stable to nephritic dehydrogenase & might so exist as given forgoing cilastatin. Inside penetrates into a cerebrospinal fluid.
|